Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisia HealthcareNZSE:PHL 33 Market Cap is NZ$31.16 Mil as of Jul. 22, 2026. GuruFocus rates NZSE:PHL with a GF Score™ of 33/100 and a GF Value™ of NZ$0.42 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Promisia Healthcare ranks worse than 75.25% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Promisia Healthcare's share price for the quarter that ended in Mar. 2026 was NZ$0.47. Promisia Healthcare's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 52.73 Mil. Therefore, Promisia Healthcare's market cap for the quarter that ended in Mar. 2026 was NZ$24.78 Mil.
Promisia Healthcare's quarterly market cap
increased
from Mar. 2025 (NZ$17.36 Mil) to Sep. 2025 (NZ$20.81 Mil) and
increased
from Sep. 2025 (NZ$20.81 Mil) to Mar. 2026 (NZ$24.78 Mil).
Promisia Healthcare's annual market cap
increased
from Mar. 2024 (NZ$0.28 Mil) to Mar. 2025 (NZ$17.36 Mil) and
increased
from Mar. 2025 (NZ$17.36 Mil) to Mar. 2026 (NZ$24.78 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Promisia Healthcare's Enterprise Value for Today is NZ$161.23 Mil.
Promisia Healthcare (NZSE:PHL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Promisia Healthcare Market Cap Related Terms
Promisia Healthcare Market Cap Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Promisia Healthcare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisia Healthcare Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's Market Cap distribution charts can be found below:
* The bar in red indicates where Promisia Healthcare's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Promisia Healthcare's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisia Healthcare (NZSE:PHL) has a Market Cap of NZ$31.16 Mil as of Jul. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Promisia Healthcare and its competitors. According to the industry distribution chart, Promisia Healthcare ranks #523 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 75.3%.
Is Promisia Healthcare's Market Cap too high?
Promisia Healthcare's current Market Cap is NZ$31.16 Mil. Based on the distribution chart, Promisia Healthcare ranks #523 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Promisia Healthcare has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Promisia Healthcare ranks #523 out of 695 companies for Market Cap. This places Promisia Healthcare in the lower half of its industry. The industry median Market Cap is 103.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.63, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Promisia Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisia Healthcare's current Market Cap is NZ$31.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.59 — trading 40.5% above its estimated fair value. The current Market Cap is NZ$31.16 Mil. Promisia Healthcare's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current Market Cap is NZ$31.16 Mil as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.59 is trading 40.5% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
Market Cap: NZ$31.16 Mil
GF Value™: NZ$0.42 vs. price of NZ$0.59 (40.5% above fair value)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
33GF Score
Get the complete analysis for NZSE:PHL
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
